annual accounts payable:
$197.40M+$10.80M(+5.79%)Summary
- As of today (June 22, 2025), EW annual accounts payable is $197.40 million, with the most recent change of +$10.80 million (+5.79%) on December 31, 2024.
- During the last 3 years, EW annual accounts payable has fallen by -$7.10 million (-3.47%).
- EW annual accounts payable is now -3.47% below its all-time high of $204.50 million, reached on December 31, 2021.
Performance
EW Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$172.40M-$25.00M(-12.66%)Summary
- As of today (June 22, 2025), EW quarterly accounts payable is $172.40 million, with the most recent change of -$25.00 million (-12.66%) on March 1, 2025.
- Over the past year, EW quarterly accounts payable has dropped by -$39.90 million (-18.79%).
- EW quarterly accounts payable is now -28.64% below its all-time high of $241.60 million, reached on March 31, 2008.
Performance
EW quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EW Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.8% | -18.8% |
| 3 y3 years | -3.5% | +8.6% |
| 5 y5 years | +9.4% | +13.8% |
EW Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +5.8% | -18.8% | +11.3% |
| 5 y | 5-year | -3.5% | +9.4% | -18.8% | +23.6% |
| alltime | all time | -3.5% | +314.7% | -28.6% | +262.2% |
EW Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $172.40M(-12.7%) |
| Dec 2024 | $197.40M(+5.8%) | $197.40M(+14.2%) |
| Sep 2024 | - | $172.80M(-7.0%) |
| Jun 2024 | - | $185.90M(-12.4%) |
| Mar 2024 | - | $212.30M(+13.8%) |
| Dec 2023 | $186.60M(-7.6%) | $186.60M(-2.1%) |
| Sep 2023 | - | $190.60M(-1.2%) |
| Jun 2023 | - | $193.00M(+6.7%) |
| Mar 2023 | - | $180.80M(-10.5%) |
| Dec 2022 | $201.90M(-1.3%) | $201.90M(+30.3%) |
| Sep 2022 | - | $154.90M(-4.7%) |
| Jun 2022 | - | $162.50M(+2.3%) |
| Mar 2022 | - | $158.80M(-22.3%) |
| Dec 2021 | $204.50M(+4.1%) | $204.50M(+46.6%) |
| Sep 2021 | - | $139.50M(-3.5%) |
| Jun 2021 | - | $144.60M(-3.9%) |
| Mar 2021 | - | $150.40M(-23.5%) |
| Dec 2020 | $196.50M(+8.9%) | $196.50M(+20.9%) |
| Sep 2020 | - | $162.50M(+5.9%) |
| Jun 2020 | - | $153.40M(+1.3%) |
| Mar 2020 | - | $151.50M(-16.0%) |
| Dec 2019 | $180.40M(+34.6%) | $180.40M(+32.7%) |
| Sep 2019 | - | $135.90M(-10.0%) |
| Jun 2019 | - | $151.00M(+2.6%) |
| Mar 2019 | - | $147.20M(+9.9%) |
| Dec 2018 | $134.00M(+14.9%) | $134.00M(0.0%) |
| Sep 2018 | - | $134.00M(+7.5%) |
| Jun 2018 | - | $124.60M(+2.8%) |
| Mar 2018 | - | $121.20M(+3.9%) |
| Dec 2017 | $116.60M(+20.1%) | $116.60M(+2.8%) |
| Sep 2017 | - | $113.40M(+8.4%) |
| Jun 2017 | - | $104.60M(+12.5%) |
| Mar 2017 | - | $93.00M(-4.2%) |
| Dec 2016 | $97.10M(+52.0%) | $97.10M(+11.6%) |
| Sep 2016 | - | $87.00M(+4.3%) |
| Jun 2016 | - | $83.40M(+6.1%) |
| Mar 2016 | - | $78.60M(+23.0%) |
| Dec 2015 | $63.90M(+9.8%) | $63.90M(-10.6%) |
| Sep 2015 | - | $71.50M(+8.0%) |
| Jun 2015 | - | $66.20M(-3.5%) |
| Mar 2015 | - | $68.60M(+17.9%) |
| Dec 2014 | $58.20M | $58.20M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $59.90M(+23.8%) |
| Dec 2013 | $48.40M(-35.2%) | $48.40M(-35.2%) |
| Dec 2012 | $74.70M(-12.1%) | $74.70M(-12.1%) |
| Dec 2011 | $85.00M(+78.6%) | $85.00M(+78.6%) |
| Dec 2010 | $47.60M(-6.8%) | $47.60M(-6.8%) |
| Dec 2009 | $51.10M(-22.1%) | $51.10M(-22.1%) |
| Dec 2008 | $65.60M(+2.7%) | $65.60M(-71.5%) |
| Sep 2008 | - | $229.90M(+1.5%) |
| Jun 2008 | - | $226.60M(-6.2%) |
| Mar 2008 | - | $241.60M(+278.1%) |
| Dec 2007 | $63.90M(+11.7%) | $63.90M(-67.9%) |
| Sep 2007 | - | $198.80M(+14.5%) |
| Jun 2007 | - | $173.60M(-3.2%) |
| Mar 2007 | - | $179.40M(+213.6%) |
| Dec 2006 | $57.20M(-70.5%) | $57.20M(-74.9%) |
| Sep 2006 | - | $227.50M(+0.4%) |
| Jun 2006 | - | $226.50M(+15.0%) |
| Mar 2006 | - | $197.00M(+1.4%) |
| Dec 2005 | $194.20M(-0.6%) | $194.20M(-5.1%) |
| Sep 2005 | - | $204.60M(+7.5%) |
| Jun 2005 | - | $190.40M(+7.9%) |
| Mar 2005 | - | $176.40M(-9.7%) |
| Dec 2004 | $195.40M(+16.9%) | $195.40M(+14.7%) |
| Sep 2004 | - | $170.30M(+9.2%) |
| Jun 2004 | - | $156.00M(-0.3%) |
| Mar 2004 | - | $156.40M(-6.5%) |
| Dec 2003 | $167.20M(-5.7%) | $167.20M(-2.8%) |
| Sep 2003 | - | $172.00M(-7.6%) |
| Jun 2003 | - | $186.10M(-1.8%) |
| Mar 2003 | - | $189.60M(+6.9%) |
| Dec 2002 | $177.30M(-3.4%) | $177.30M(+1.3%) |
| Sep 2002 | - | $175.00M(-5.7%) |
| Jun 2002 | - | $185.50M(+11.5%) |
| Mar 2002 | - | $166.30M(-9.4%) |
| Dec 2001 | $183.50M(+3.7%) | $183.50M(+16.7%) |
| Sep 2001 | - | $157.20M(+4.9%) |
| Jun 2001 | - | $149.90M(-10.5%) |
| Mar 2001 | - | $167.40M(-5.4%) |
| Dec 2000 | $177.00M | $177.00M(+39.6%) |
| Sep 2000 | - | $126.80M(+4.8%) |
| Jun 2000 | - | $121.00M(-0.8%) |
| Mar 2000 | - | $122.00M |
FAQ
- What is Edwards Lifesciences annual accounts payable?
- What is the all time high annual accounts payable for Edwards Lifesciences?
- What is Edwards Lifesciences annual accounts payable year-on-year change?
- What is Edwards Lifesciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly accounts payable year-on-year change?
What is Edwards Lifesciences annual accounts payable?
The current annual accounts payable of EW is $197.40M
What is the all time high annual accounts payable for Edwards Lifesciences?
Edwards Lifesciences all-time high annual accounts payable is $204.50M
What is Edwards Lifesciences annual accounts payable year-on-year change?
Over the past year, EW annual accounts payable has changed by +$10.80M (+5.79%)
What is Edwards Lifesciences quarterly accounts payable?
The current quarterly accounts payable of EW is $172.40M
What is the all time high quarterly accounts payable for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly accounts payable is $241.60M
What is Edwards Lifesciences quarterly accounts payable year-on-year change?
Over the past year, EW quarterly accounts payable has changed by -$39.90M (-18.79%)